Article Details

POINT Biopharma completes randomization in PNT2002's phase 3 SPLASH trial

Retrieved on: 2023-01-13 17:06:52

Tags for this article:

Click the tags to see associated articles and topics

POINT Biopharma completes randomization in PNT2002's phase 3 SPLASH trial. View article details on HISWAI: https://www.canadianmanufacturing.com/manufacturing/point-biopharma-completes-randomization-in-pnt2002s-phase-3-splash-trial-288525/

Excerpt

Enrollment for the randomization phase of SPLASH completed prior to EOY 2022, meeting previous guidance. INDIANAPOLIS — POINT Biopharma Global Inc., a ...

Article found on: www.canadianmanufacturing.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up